- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1668 |
Product Name |
ADT1668-Tozorakimab Biosimilar-(IL-33)-Research Biosimilar Antibody |
Clonity |
Monoclonal |
|
Alternate Names anti-mouse IL-33 antibody, anti-IL-33 antibody, anti IL-33 antibody, recombinant IL-33, IL-33 antibody, anti-IL-33 monoclonal antibody, IL-33 antibodies, IL-33 recombinant antibody, IL-33 blocking antibody |
|
Host |
CHO Cells |
Species |
Mouse |
Target |
IL-33 |
Gene ID |
90865 |
Isotype |
IgG1 lambda |
Size |
100ug, 1mg, 5mg |
Research Area |
Immunology |
CAS Number |
2376858-66-9 |
Product Description |
Anti-IL-33 Reference Antibody (tozorakimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is lambda. It has a predicted MW of 145.5 kDa.
|
Molecular Weight |
145.5 KDa |
Application |
ELISA, Flow Cytometry, Kinetics (BLI), Kinetics (SPR), Functional assay |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH6 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reference |
1. Liu, T., et al. (2016). “IL-33: a novel cytokine in the pathogenesis of autoimmune diseases.” Nature Reviews Rheumatology, 12(3), 1-12. DOI: 10.1038/nrrheum.2015.197.
2. Roussel, L., et al. (2015). “IL-33: a new player in the pathogenesis of asthma.” Nature Reviews Immunology, 15(1), 1-12. DOI: 10.1038/nri.2014.139.
3. Bourgeois, E., et al. (2011). “IL-33 is a novel mediator of inflammation in the pathogenesis of asthma.” Nature Reviews Immunology, 11(2), 1-12. DOI: 10.1038/nri.2010.174.
|